Oramed Pharmaceuticals Inc. (ORMP) vs RxSight, Inc. (RXST)

A side-by-side comparison of Oramed Pharmaceuticals Inc. and RxSight, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ORMP vs RXST

growth of $100 · dividends reinvested · last 5y
ORMP -66.3% (-19.5%/yr)RXST -70.3% (-21.5%/yr)ORMP compounded faster over this window
0100200300400Start $10020222023202420252026$34$30
ORMP RXST

ORMP vs RXST: by the numbers

  • •RXST is the larger company ($192M vs $179M market cap).
  • •ORMP is profitable (3202.50% net margin) while RXST runs a net loss (-36.80%).
  • •ORMP pays a dividend (5.59% yield), while RXST has no payments in the available dividend history.

Metrics side by side

Valuation

MetricORMPRXST
P/E ratio1.07N/A
P/S ratioN/A1.51
P/B ratio0.560.73

Profitability

MetricORMPRXST
Gross margin0.65%77.50%
Operating margin-754.40%-43.20%
Net margin3202.50%-36.80%
ROE55.08%-17.83%
ROIC-3.21%-20.24%

Dividends

MetricORMPRXST
Dividend yield5.59%N/A
Payout ratio6.08%N/A

Growth (annualized)

MetricORMPRXST
Revenue CAGR (5Y)N/A48.85%
Total return CAGR (5Y)-25.80%-19.19%

Frequently asked

Does ORMP or RXST pay a bigger dividend?
ORMP pays a dividend (5.59% yield), while RXST has no payments in the available dividend history.
Is ORMP or RXST more profitable?
ORMP runs the higher net margin — ORMP at 3202.50% versus RXST at -36.80%.
How have ORMP and RXST total returns compared?
Over the past 5 years, ORMP delivered -25.80% and RXST delivered -19.19% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.